Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update
10 mai 2023 16h05 HE
|
Rani Therapeutics, LLC
- Announced partnership with Celltrion on development of RT-111, a RaniPill GO capsule containing a biosimilar for the monoclonal antibody ustekinumab - - Received preliminary feedback from FDA on...
Immuneering Reports First Quarter 2023 Financial Results and Provides Business Updates
04 mai 2023 16h05 HE
|
Immuneering Corporation
- Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104 Universal-RAS Program presented at American Association for Cancer Research (AACR) annual meeting - -First...
Smart Sand, Inc. Announces Timing of First Quarter 2022 Earnings Release and Investor Conference Call
21 avr. 2022 16h15 HE
|
Smart Sand, Inc.
THE WOODLANDS, Texas, April 21, 2022 (GLOBE NEWSWIRE) -- Smart Sand, Inc. (NASDAQ: SND) (the “Company”) announced today that it will release its first quarter financial results after the market...
SMART SAND, INC. ANNOUNCES UPDATES ON MANAGING MARKET VOLATILITY
07 avr. 2020 06h00 HE
|
Smart Sand, Inc.
THE WOODLANDS, Texas, April 07, 2020 (GLOBE NEWSWIRE) -- Smart Sand, Inc. (NASDAQ: SND) (the “Company”) provided an update on the current market environment. The recent decline in oil prices...
Smart Sand, Inc. Announces Timing of First Quarter 2018 Earnings Release and Investor Conference Call
01 mai 2018 11h10 HE
|
Smart Sand, Inc.
THE WOODLANDS, Texas, May 01, 2018 (GLOBE NEWSWIRE) -- Smart Sand, Inc. (NASDAQ:SND) (the “Company”) announced today that it will release its first quarter 2018 financial results before the market...
Private Equity and Venture Capital Funds Extended String of Positive Quarterly Returns to Eight During First Three Months of 2011
10 août 2011 08h45 HE
|
Cambridge Associates
BOSTON, MA--(Marketwire - Aug 10, 2011) - The quarter ending March 31, 2011, was the eighth in a row to yield positive returns for private equity and venture capital funds, according to Cambridge...